|
1
|
Zhang X, Nie Y, Du Y, Cao J, Shen B and Li
Y: MicroRNA-181a promotes gastric cancer by negatively regulating
tumor suppressor KLF6. Tumour Biol. 33:1589–1597. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang M, Li C, Nie H, et al: Down-regulated
miR-625 suppresses invasion and metastasis of gastric cancer by
targeting ILK. FEBS Lett. 586:2382–2388. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li Z, Cao Y, Jie Z, et al: miR-495 and
miR-551a inhibit the migration and invasion of human gastric cancer
cells by directly interacting with PRL-3. Cancer Lett. 323:41–47.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hua Y, Duan S, Murmann AE, et al:
miRConnect: identifying effector genes of miRNAs and miRNA families
in cancer cells. PLoS One. 6:e265212011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim VN, Han J and Siomi MC: Biogenesis of
small RNAs in animals. Nat Rev Mol Cell Biol. 10:126–139. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schickel R, Boyerinas B, Park SM and Peter
ME: MicroRNAs: key players in the immune system, differentiation,
tumorigenesis and cell death. Oncogene. 27:5959–5974. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Negrini M, Nicoloso MS and Calin GA:
MicroRNAs and cancer - new paradigms in molecular oncology. Curr
Opin Cell Biol. 21:470–479. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park SM, Gaur AB, Lengyel E and Peter ME:
The miR-200 family determines the epithelial phenotype of cancer
cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes
Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Howe EN, Cochrane DR and Richer JK:
Targets of miR-200c mediate suppression of cell motility and
anoikis resistance. Breast Cancer Res. 13:R452011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schliekelman MJ, Gibbons DL, Faca VM, et
al: Targets of the tumor suppressor miR-200 in regulation of the
epithelial-mesenchymal transition in cancer. Cancer Res.
71:7670–7682. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Slabakova E, Pernicova Z, Slavickova E,
Starsichova A, Kozubik A and Soucek K: TGF-beta1-induced EMT of
non-transformed prostate hyperplasia cells is characterized by
early induction of SNAI2/Slug. Prostate. 71:1332–1343.
2011.PubMed/NCBI
|
|
14
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Davalos V, Moutinho C, Villanueva A, et
al: Dynamic epigenetic regulation of the microRNA-200 family
mediates epithelial and mesenchymal transitions in human
tumorigenesis. Oncogene. 31:2062–2074. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao F, Zhang Q, Kang C, et al:
Suppression of matrix metalloproteinase-9 expression by RNA
interference inhibits SGC7901 gastric adenocarcinoma cell growth
and invasion in vitro and in vivo. Med Oncol. 27:774–784. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Su J, Zhang A, Shi Z, et al: MicroRNA-200a
suppresses the Wnt/β-catenin signaling pathway by interacting with
β-catenin. Int J Oncol. 40:1162–1170. 2012.
|
|
18
|
Gregory PA, Bert AG, Paterson EL, et al:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol Chem.
283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Burk U, Schubert J, Wellner U, et al: A
reciprocal repression between ZEB1 and members of the miR-200
family promotes EMT and invasion in cancer cells. EMBO Rep.
9:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wiklund ED, Bramsen JB, Hulf T, et al:
Coordinated epigenetic repression of the miR-200 family and miR-205
in invasive bladder cancer. Int J Cancer. 128:1327–1334. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Barron N, Keenan J, Gammell P, et al:
Biochemical relapses following radical prostatectomy and miR-200a
levels in prostate cancer. Prostate. 7:1193–1199. 2011.PubMed/NCBI
|
|
23
|
Guttilla IK, Adams BD and White BA:
ERalpha, microRNAs, and the epithelial-mesenchymal transition in
breast cancer. Trends Endocrinol Metab. 23:73–82. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roybal JD, Zang Y, Ahn YH, et al: miR-200
inhibits lung adenocarcinoma cell invasion and metastasis by
targeting Flt1/VEGFR1. Mol Cancer Res. 9:25–35. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Snowdon J, Zhang X, Childs T, Tron VA and
Feilotter H: The microRNA-200 family is upregulated in endometrial
carcinoma. PLoS One. 6:e228282011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mateescu B, Batista L, Cardon M, et al:
miR-141 and miR-200a act on ovarian tumorigenesis by controlling
oxidative stress response. Nat Med. 17:1627–1635. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Saydam O, Shen Y, Wurdinger T, et al:
Downregulated microRNA-200a in meningiomas promotes tumor growth by
reducing E-cadherin and activating the Wnt/beta-catenin signaling
pathway. Mol Cell Biol. 29:5923–5940. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xia H, Ng SS, Jiang S, et al:
miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially
inhibits nasopharyngeal carcinoma cell growth, migration and
invasion. Biochem Biophys Res Commun. 391:535–541. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Han L, Yang Y, Yue X, et al: Inactivation
of PI3K/AKT signaling inhibits glioma cell growth through
modulation of beta-catenin-mediated transcription. Brain Res.
1366:9–17. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Casas E, Kim J, Bendesky A, Ohno-Machado
L, Wolfe CJ and Yang J: Snail2 is an essential mediator of
Twist1-induced epithelial mesenchymal transition and metastasis.
Cancer Res. 71:245–254. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ip YT, Park RE, Kosman D, Yazdanbakhsh K
and Levine M: Dorsal-twist interactions establish snail expression
in the presumptive mesoderm of the Drosophila embryo. Genes
Dev. 6:1518–1530. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Leptin M: Twist and snail as positive and
negative regulators during Drosophila mesoderm development.
Genes Dev. 5:1568–1576. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang J, Mani SA, Donaher JL, et al: Twist,
a master regulator of morphogenesis, plays an essential role in
tumor metastasis. Cell. 117:927–939. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Reinhold MI, Kapadia RM, Liao Z and Naski
MC: The Wnt-inducible transcription factor Twist1 inhibits
chondrogenesis. J Biol Chem. 281:1381–1388. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Conacci-Sorrell M, Simcha I, Ben-Yedidia
T, Blechman J, Savagner P and Ben-Ze’Ev A: Autoregulation of
E-cadherin expression by cadherin-cadherin interactions: the roles
of beta-catenin signaling, Slug, and MAPK. J Cell Biol.
163:847–857. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kurashige J, Kamohara H, Watanabe M, et
al: MicroRNA-200b regulates cell proliferation, invasion, and
migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg
Oncol. 19:656–664. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Radisky DC: miR-200c at the nexus of
epithelial-mesenchymal transition, resistance to apoptosis, and the
breast cancer stem cell phenotype. Breast Cancer Res. 13:1102011.
View Article : Google Scholar : PubMed/NCBI
|
